- Home
- MRVI vs HTD Comparison
MRVI vs HTD Comparison
Compare MRVI & HTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- HTD
- Stock Information
- Founded
- MRVI 2020
- HTD 2004
- Country
- MRVI United States
- HTD United States
- Employees
- MRVI N/A
- HTD N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- HTD Finance Companies
- Sector
- MRVI Health Care
- HTD Finance
- Exchange
- MRVI Nasdaq
- HTD Nasdaq
- Market Cap
- MRVI 809.2M
- HTD 780.2M
- IPO Year
- MRVI 2020
- HTD N/A
- Fundamental
- Price
- MRVI $4.77
- HTD $22.52
- Analyst Decision
- MRVI Buy
- HTD
- Analyst Count
- MRVI 10
- HTD 0
- Target Price
- MRVI $10.28
- HTD N/A
- AVG Volume (30 Days)
- MRVI 1.8M
- HTD 92.3K
- Earning Date
- MRVI 02-25-2025
- HTD 01-01-0001
- Dividend Yield
- MRVI N/A
- HTD 8.59%
- EPS Growth
- MRVI N/A
- HTD N/A
- EPS
- MRVI N/A
- HTD N/A
- Revenue
- MRVI $276,920,000.00
- HTD N/A
- Revenue This Year
- MRVI N/A
- HTD N/A
- Revenue Next Year
- MRVI $2.25
- HTD N/A
- P/E Ratio
- MRVI N/A
- HTD N/A
- Revenue Growth
- MRVI N/A
- HTD N/A
- 52 Week Low
- MRVI $4.28
- HTD $16.17
- 52 Week High
- MRVI $11.56
- HTD $22.13
- Technical
- Relative Strength Index (RSI)
- MRVI 39.85
- HTD 53.59
- Support Level
- MRVI $4.38
- HTD $21.43
- Resistance Level
- MRVI $6.21
- HTD $22.75
- Average True Range (ATR)
- MRVI 0.39
- HTD 0.36
- MACD
- MRVI -0.09
- HTD 0.07
- Stochastic Oscillator
- MRVI 21.31
- HTD 82.20
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest
John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.